Posts by John

Latin Clinical Trial Center and PhaseWell Research partner to scale clinical trials in Puerto Rico, enhancing patient access to innovative new therapies.

Nanvuranlat enters Phase 3 clinical trials following FDA alignment. Learn about the latest developments in this promising oncology therapeutic candidate.

Edgewise Therapeutics announces positive Phase II results for EDG-7500 in treating hypertrophic cardiomyopathy. See how this breakthrough impacts heart care.

Discover why India’s pharma growth is shifting from price hikes to volume-driven demand and what this means for the future of the healthcare industry.

Explore why the Indian pharmaceutical industry is set for sustained double-digit growth driven by complex generics, PLI schemes, and rising domestic demand.

New Phase II data reveals that adding ligufalimab to azacitidine and venetoclax improves overall survival for AML patients. Learn the latest clinical impact.

Discover how closed-loop DBS is revolutionizing CNS clinical trials. Learn why your protocol needs to adapt to real-time neuro-monitoring and data integration.

Discover how small ClinOps teams effectively manage single-drug, multi-indication trials through strategic planning, advanced technology, and lean models.

A new study reveals a lack of medical research in India's private hospitals, urging a shift toward evidence-based medicine to improve patient outcomes.

New NIH-funded research confirms that weight loss and regular exercise significantly lower the risk of chronic disease in people with prediabetes.